Lamivudine for Solid Tumors

NCT06494579 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Solid Tumors

Interventions

DRUG: Lamivudine
DRUG: PD-L1 Blocker

Sponsor

Thomas Marron